ArticleBlood neoplasia2026

Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation study.

Tariq Kewan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.